| pubmed-article:11591513 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0009171 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0026548 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C1518591 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0205430 | lld:lifeskim |
| pubmed-article:11591513 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:11591513 | pubmed:issue | 20 | lld:pubmed |
| pubmed-article:11591513 | pubmed:dateCreated | 2001-10-9 | lld:pubmed |
| pubmed-article:11591513 | pubmed:abstractText | A series of new N-substituted derivatives of morphinan was synthesized and their binding affinity for the three opioid receptors (mu, delta, and kappa) was determined. A paradoxical effect of N-propargyl (MCL-117) and N-(3-iodoprop-(2E)-enyl) (MCL-118) substituents on the binding affinities for the mu and kappa opioid receptors was observed. All of these novel derivatives showed a preference for the mu and kappa versus delta binding. | lld:pubmed |
| pubmed-article:11591513 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11591513 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11591513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11591513 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11591513 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11591513 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:NeumeyerJ LJL | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:CohenD JDJ | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:MelloN KNK | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:BidlackJ MJM | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:GuX HXH | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:NegusS SSS | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:van VlietL... | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:RusoviciD EDE | lld:pubmed |
| pubmed-article:11591513 | pubmed:author | pubmed-author:DeNunzioN JNJ | lld:pubmed |
| pubmed-article:11591513 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11591513 | pubmed:day | 22 | lld:pubmed |
| pubmed-article:11591513 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:11591513 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11591513 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11591513 | pubmed:pagination | 2735-40 | lld:pubmed |
| pubmed-article:11591513 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:meshHeading | pubmed-meshheading:11591513... | lld:pubmed |
| pubmed-article:11591513 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11591513 | pubmed:articleTitle | Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. | lld:pubmed |
| pubmed-article:11591513 | pubmed:affiliation | Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA. neumeyer@mclean.harvard.edu | lld:pubmed |
| pubmed-article:11591513 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11591513 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11591513 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11591513 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11591513 | lld:pubmed |
